Immune dysregulation and vascular risk in HIV-infected patients: implications for clinical care
- PMID: 21220778
- PMCID: PMC3071222
- DOI: 10.1093/infdis/jiq084
Immune dysregulation and vascular risk in HIV-infected patients: implications for clinical care
Comment on
-
T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women.J Infect Dis. 2011 Feb 15;203(4):452-63. doi: 10.1093/infdis/jiq071. Epub 2011 Jan 10. J Infect Dis. 2011. PMID: 21220772 Free PMC article.
References
-
- Klein D, Hurley LB, Quesenberry CP, Jr, Sidney S. Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? J Acquir Immune Defic Syndr. 2002;30:471–7. - PubMed
-
- Worm SW, Sabin C, Weber R, et al. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study. J Infect Dis. 2010;201:318–30. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources